The Biden administration said today it proposes to continue a nearly 30% reduction in Medicare Part B reimbursement for hospitals’ 340B-purchased drugs.
The Trump administration implemented the payment reduction in January 2018. Hospital groups say it costs affected 340B hospitals $1.6 billion a year, and they have lobbied the new Democratic administration to end the cut. They say it hurts safety-net hospitals and low-income patients, undermines the 340B program, and does virtually nothing to reduce Medicare beneficiaries’ out of pocket expenses.
The Biden administration said today it proposes to continue a nearly 30% reduction in Medicare Part B reimbursement for hospitals’ 340B-purchased drugs.
The Trump administration implemented the payment reduction in January 2018. Hospital groups say it costs affected 340B hospitals $1.6 billion a year, and they have lobbied the new Democratic administration to end the cut. They say it hurts safety-net hospitals and low-income patients, undermines the 340B program, and does virtually nothing to reduce Medicare beneficiaries’ out of pocket expenses.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.